DS
FOMX

David Shaw’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

David Shaw’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21,880
Closed -$52K – 4127
2019
Q2 		$52K Sell
21,880
-1,979
-8% -$5.91K ﹤0.01% 3586
2019
Q1 		$89K Sell
23,859
-2,900
-11% -$10.9K ﹤0.01% 3485
2018
Q4 		$96K Sell
26,759
-199,251
-88% -$867K ﹤0.01% 3644
2018
Q3 		$1.3M Buy
226,010
+172,248
+320% +$985K ﹤0.01% 2509
2018
Q2 		$269K Buy
53,762
+7,336
+16% +$37.8K ﹤0.01% 3421
2018
Q1 		$238K Buy
46,426
+9,232
+25% +$55.6K ﹤0.01% 3251
2017
Q4 		$224K Buy
+37,194
New +$224K ﹤0.01% 3383
2017
Q3 		– Sell
-16,327
Closed -$76K – 3699
2017
Q2 		$76K Sell
16,327
-50,046
-75% -$223K ﹤0.01% 3284
2017
Q1 		$329K Buy
66,373
+23,327
+54% +$224K ﹤0.01% 2930
2016
Q4 		$478K Buy
43,046
+22,688
+111% +$213K ﹤0.01% 2881
2016
Q3 		$189K Sell
20,358
-32,043
-61% -$268K ﹤0.01% 3212
2016
Q2 		$333K Sell
52,401
-7,893
-13% -$52.4K ﹤0.01% 2986
2016
Q1 		$393K Buy
60,294
+5,906
+11% +$38.1K ﹤0.01% 2902
2015
Q4 		$441K Buy
54,388
+33,103
+156% +$247K ﹤0.01% 3156
2015
Q3 		$156K Sell
21,285
-20,754
-49% -$212K ﹤0.01% 3556
2015
Q2 		$431K Buy
+42,039
New +$465K ﹤0.01% 3243

Other funds holding FOMX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DAM
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

David Shaw's FOMX Position: Q3 2019 in Review

David Shaw sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2019, closing a stake of 21,880 shares — an estimated $52K sold.

David Shaw first reported a position in FOMX in Q2 2015 and held it in 16 quarters. The position peaked at $1.3M in Q3 2018. 59 funds tracked by Wall St. Rank hold FOMX as of Q3 2019.

  • David Shaw reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • David Shaw sold 21,880 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2019, an estimated $52K.
  • David Shaw first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 16 quarters.
  • David Shaw's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.3M in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2019.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.